Sino-Argi Leading Biosciences (603970) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.227x

Based on the latest financial reports, Sino-Argi Leading Biosciences (603970) has a cash flow conversion efficiency ratio of -0.227x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-390.12 Million ≈ $-57.09 Million USD) by net assets (CN¥1.72 Billion ≈ $251.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sino-Argi Leading Biosciences balance sheet independence to measure how much of total assets are equity-financed.

Sino-Argi Leading Biosciences - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Sino-Argi Leading Biosciences's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603970 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Sino-Argi Leading Biosciences Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sino-Argi Leading Biosciences ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shanghai Xujiahui Commercial Co Ltd
SHE:002561
0.021x
Sappi Ltd
JSE:SAP
0.023x
Shenyang Chemical Industry Co Ltd
SHE:000698
0.142x
Wolfspeed, Inc.
NASDAQ:WOLF
-0.005x
Codere Online US Corp
NASDAQ:CDRO
0.181x
Tae Kwang Corporation
KQ:023160
0.012x
Zhongfu Information Inc
SHE:300659
-0.012x
Allogene Therapeutics Inc
NASDAQ:ALLO
-0.094x

Annual Cash Flow Conversion Efficiency for Sino-Argi Leading Biosciences (2012–2025)

The table below shows the annual cash flow conversion efficiency of Sino-Argi Leading Biosciences from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Sino-Argi Leading Biosciences market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.73 Billion
≈ $252.90 Million
CN¥-78.31 Million
≈ $-11.46 Million
-0.045x -124.80%
2024-12-31 CN¥1.68 Billion
≈ $246.23 Million
CN¥307.40 Million
≈ $44.98 Million
0.183x +131.66%
2023-12-31 CN¥1.59 Billion
≈ $233.27 Million
CN¥-919.85 Million
≈ $-134.60 Million
-0.577x -155.78%
2022-12-31 CN¥1.48 Billion
≈ $217.23 Million
CN¥1.54 Billion
≈ $224.71 Million
1.034x +307.16%
2021-12-31 CN¥1.28 Billion
≈ $187.44 Million
CN¥325.42 Million
≈ $47.62 Million
0.254x -17.50%
2020-12-31 CN¥1.14 Billion
≈ $167.32 Million
CN¥352.12 Million
≈ $51.53 Million
0.308x +46.94%
2019-12-31 CN¥1.04 Billion
≈ $152.84 Million
CN¥218.90 Million
≈ $32.03 Million
0.210x +205.35%
2018-12-31 CN¥957.07 Million
≈ $140.05 Million
CN¥65.69 Million
≈ $9.61 Million
0.069x -88.54%
2017-12-31 CN¥866.35 Million
≈ $126.77 Million
CN¥518.83 Million
≈ $75.92 Million
0.599x +69.73%
2016-12-31 CN¥431.42 Million
≈ $63.13 Million
CN¥152.22 Million
≈ $22.27 Million
0.353x +147.82%
2015-12-31 CN¥344.56 Million
≈ $50.42 Million
CN¥-254.22 Million
≈ $-37.20 Million
-0.738x -630.24%
2014-12-31 CN¥290.44 Million
≈ $42.50 Million
CN¥40.41 Million
≈ $5.91 Million
0.139x +145.88%
2013-12-31 CN¥262.68 Million
≈ $38.44 Million
CN¥-79.66 Million
≈ $-11.66 Million
-0.303x -166.96%
2012-12-31 CN¥241.63 Million
≈ $35.36 Million
CN¥109.43 Million
≈ $16.01 Million
0.453x --

About Sino-Argi Leading Biosciences

SHG:603970 China Agricultural Inputs
Market Cap
$405.14 Million
CN¥2.77 Billion CNY
Market Cap Rank
#13362 Global
#3956 in China
Share Price
CN¥10.30
Change (1 day)
+0.19%
52-Week Range
CN¥9.63 - CN¥14.45
All Time High
CN¥25.13
About

Sino-Agri Leading Biosciences Co.,Ltd engages in pesticide distribution in China and internationally. The company sells technical materials, formulations, and related products. It also provides plant protection technology services; and crop health solutions, including technical guidance, application demonstration, and processing and packaging of plant protection products. In addition, the company… Read more